Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry

Abstract Diagnostic and molecular genetic testing are key in advancing the treatment of acute myeloid leukemia (AML), yet little is known about testing patterns outside of clinical trials, especially in older patients. We analyzed diagnostic and molecular testing patterns over time in 565 patients a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daniel A. Pollyea, Tracy I. George, Mehrdad Abedi, Rafael Bejar, Christopher R. Cogle, Kathryn Foucar, Guillermo Garcia‐Manero, David L. Grinblatt, Rami S. Komrokji, Jaroslaw P. Maciejewski, Dennis A. Revicki, Gail J. Roboz, Michael R. Savona, Bart L. Scott, Mikkael A. Sekeres, Michael A. Thompson, Sandra E. Kurtin, Chrystal U. Louis, Melissa Nifenecker, E. Dawn Flick, Arlene S. Swern, Pavel Kiselev, David P. Steensma, Harry P. Erba
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2020-07-01
coleção:	eJHaem
Assuntos:	acute myeloid leukemia diagnostic testing leukemia diagnosis leukemia therapy molecular testing registry
Acesso em linha:	https://doi.org/10.1002/jha2.16
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!